Wang Zhangzheng

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2022-2026

2026

Kovács, P., Wang, Z., Hajdú, T., Juhász, K. Z., Katona, É., Takács, R. Á., Vágó, J., Zákány, R., Póliska, S., Szentesi, P., Csernoch, L., Matta, C.: Microgravity-induced transcriptional reprogramming in embryonic chicken limb bud-derived chondrogenic cultures.
Front. Cell. Dev. Biol. 14, 1-16, (article identifier: 1746313), 2026.

doi DEA

Journal metrics:

Q1 Cell Biology (2024)

Q1 Developmental Biology (2024)

Kovács, P., Brázda, P., Hajdú, T., Harsányi, B., Juhász, K. Z., Takács, R. Á., Vágó, J., Wang, Z., Coveney, C., Boocock, D. J., Matta, C.: Podocalyxin and ciliary neurotrophic factor receptor are novel components of the surfaceome of chondrogenic cells.
Cell Commun. Signal. 24 (8), 1-20, 2026.

doi DEA WoS Scopus

Journal metrics:

D1 Biochemistry (2024)

Q1 Cell Biology (2024)

Q1 Molecular Biology (2024)

2025

Mo, L., Wang, Z., Jiang, M., Zhou, C., Ma, C., Fan, Y., He, W., Chen, Z., Liu, Y.: The pathomechanism of bone marrow edema in the femoral head necrosis with pericollapse stage.
Sci Rep. 15 (1), 1-15, (article identifier: 1166), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Multidisciplinary (2024)

2024

Chen, Z., Jiang, M., Mo, L., Zhou, C., Huang, H., Ma, C., Wang, Z., Fan, Y., Chen, Z., Fang, B., Liu, Y.: A natural agent, 5-deoxycajanin, mitigates estrogen-deficiency bone loss via modulating osteoclast-osteoblast homeostasis.
Int. Immunopharmacol. 141, 1-12, (article identifier: 112906), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Immunology

Q2 Immunology and Allergy

Q1 Pharmacology

Ma, C., Wang, Z., Mo, L., Wang, X., Zhou, G., Yi, C., Niu, W., Liu, Y.: Tanshinone I attenuates estrogen-deficiency bone loss via inhibiting RANKL-induced MAPK and NF-?B signaling pathways.
Int. Immunopharmacol. 127, 1-9, (article identifier: 111322), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Immunology

Q2 Immunology and Allergy

Q1 Pharmacology

2023

Ma, C., Mo, L., Wang, Z., Peng, D., Zhou, C., Niu, W., Liu, Y., Chen, Z.: Dihydrotanshinone I attenuates estrogen-deficiency bone loss through RANKL-stimulated NF-?B, ERK and NFATc1 signaling pathways.
Int. Immunopharmacol. 123, 1-9, (article identifier: 110572), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Immunology

Q2 Immunology and Allergy

Q1 Pharmacology

Li, J., Mo, L., Bai, G., Wang, Z., Zhang, H., Li, J.: One in five patients require conversion to arthroplasty after non-vascularized bone grafts in patients with osteonecrosis of the femoral head: a systematic review.
J Orthop Surg Res. 18 (1), 1-12, (article identifier: 77), 2023.

doi DEA WoS Scopus

2022

Mo, L., Li, J., Wang, Z., Huang, F., Xin, P., Zhou, C., He, W., Liu, Y.: Influence of less invasive hip preservation surgery on subsequent hip arthroplasty for osteonecrosis of the femoral head.
J. Hip. Preserv. Surg. 9 (3), 197-205, 2022.

doi DEA WoS

Mo, L., Wang, Z., Huang, H., Li, J., Ma, C., Zhang, J., Huang, F., He, W., Liu, Y., Zhou, C.: Integrated Analysis of Crucial Genes and miRNAs Associated with Osteoporotic Fracture of Type 2 Diabetes.
Biomed Res. Int. 2022 (1), 1-18, (article identifier: 3921570), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q2 Immunology and Microbiology (miscellaneous)

Q2 Medicine (miscellaneous)

10.

Mo, L., Ma, C., Wang, Z., Li, J., He, W., Niu, W., Chen, Z., Zhou, C., Liu, Y.: Integrated Bioinformatic Analysis of the Shared Molecular Mechanisms Between Osteoporosis and Atherosclerosis.
Front Endocrinol (Lausanne). 13, 1-15, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism